News

Published on 14 Feb 2025 on Zacks · via Yahoo Finance

AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates


Article preview image

AtriCure (ATRC) delivered earnings and revenue surprises of 46.67% and 0.01%, respectively, for the...

NASDAQ.ATRC price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of 46.67% and 0.01%, respectively, for t...

Zacks · via Yahoo Finance 14 Feb 2025

Why AtriCure, Inc. (ATRC) Is Skyrocketing Now

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article,...

Insider Monkey · via Yahoo Finance 23 Jan 2025

AtriCure, Inc. (NASDAQ:ATRC) Shares Could Be 26% Below Their Intrinsic Value...

Key Insights AtriCure's estimated fair value is US$49.02 based on 2 Stage Free Cash Flow to Equit...

Simply Wall St. · via Yahoo Finance 28 Nov 2024

Is AtriCure, Inc. (NASDAQ:ATRC) Trading At A 48% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, AtriCure fair value estimate is US$39.98...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

AtriCure (ATRC) Stock Slipped on Competition Threat

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small...

Insider Monkey · via Yahoo Finance 18 Jun 2024

AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript

AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript May 2, 2024 AtriCure, Inc. isn't on...

Insider Monkey via Yahoo Finance 3 May 2024

The past three years for AtriCure (NASDAQ:ATRC) investors has not been profitable

As every investor would know, not every swing hits the sweet spot. But really big losses can real...

Simply Wall St. via Yahoo Finance 3 May 2024

AtriCure executive sells shares worth over $36,000 By Investing.com

In a recent transaction, Justin J. Noznesky, the Chief Marketing & Strategy Officer of AtriCure, ...

Investing.com 3 May 2024

AtriCure shares target cut $7, maintains Buy rating By Investing.com

On Thursday, BTIG adjusted its outlook on AtriCure Inc. (NASDAQ:ATRC), reducing the price target ...

Investing.com 3 May 2024

AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management

AtriCure, Inc. ATRC recently announced the launch of the cryoSPHERE+ cryoablation probe, which us...

Zacks via Yahoo Finance 20 Apr 2024